Chlorhexidine disinfectant serves as a potential chemical adjuvant during the surgical treatment of bone tumors.
- After surgical treatment of bone cancer, irrigation helps eliminate any leftover bone cancer cells that could cause a recurrence
- 0.05% CHG solution appears to be the best in eliminating leftover tumor cells following surgery
Chlorhexidine for Post-Surgical Treatment of Bone Cancer
Some patients with bone malignancies undergo a surgical treatment called intralesional curettage. The tumor is removed during this treatment while trying to keep as much healthy bone as feasible. Irrigating the surgical area of the bone with a chemical solution is a typical adjuvant therapy. The goal of this irrigation is to eliminate any leftover cells that could cause a recurrence or reseed of the tumor.Giant cell tumor, a benign but aggressive tumor, and chondrosarcoma, a kind of bone cancer, were employed as cultures in the research. Six different solutions – sterile water, 0.9% saline, 70% ethanol, 3% hydrogen peroxide, 0.05% CHG, and 0.3% povidone-iodine – were used to treat tumor cell cultures.
Only CHG out of the six treatments showed cell-killing efficiency comparable to a control solution with 100% cytotoxicity, and this result was shown regardless of the length of the treatment (i.e., 2 minutes or 5 minutes).
None of the other treatments came close to CHG's capacity to kill cells. Only two solutions- sterile water and hydrogen peroxide - outperformed a low-cytotoxicity control treatment. Saline, ethanol, and povidone-iodine, the other three solutions that were examined, displayed minimal to no cytotoxicity.
Medicinal Uses of Chlorhexidine
A well-known disinfectant with several medicinal applications, including as a topical antiseptic treatment before surgery. In comparison to certain currently utilized drugs, the researchers state that “CHG is routinely used and easily accessible, with shown in vivo safety in other surgical applications.”The researchers stress that additional research will be required to assess the effectiveness of CHG irrigation in surgical patients. Dr. Thompson commented, “We believe it is important to continue to explore better ways to achieve durable local control of benign aggressive tumors like giant cell tumor of bone, which are associated with a high risk of local recurrence when treated with conventional extended intralesional curettage.”